Find the right fit for you - faster
Get tailored insights about working at Verge Genomics in one quick step.
Verge Genomics Snapshot
Accelerate development of life-saving treatments for patients with neurodegenerative diseases, including ALS, Parkinson’s Disease, and Alzheimer’s Disease.
Values:
- Patient Driven - Inspired and driven by the people who need us
- Team of Founders - We are each responsible for the success of the company and each other
- Transparency - Express ourselves with candor
- Growth Mindset - Always seeking opportunities to improve
- Grit - Persevere in the face of adversity
- Rigor - Supporting quality science
Values:
- Patient Driven - Inspired and driven by the people who need us
- Team of Founders - We are each responsible for the success of the company and each other
- Transparency - Express ourselves with candor
- Growth Mindset - Always seeking opportunities to improve
- Grit - Persevere in the face of adversity
- Rigor - Supporting quality science
Currently, it takes 12 years and $2.6 billion to get a single drug to market, with the drug discovery and development process costing $1.4 billion. At Verge Genomics, we believe there is a better way: we aim to improve the traditional drug discovery process with approaches based on systems biology, machine learning on human patient data, and drug screening in human cell cultures.
Founded in 2015, we’ve raised $32 million in Series A financing to build a next-generation biopharmaceutical company and are looking for exceptional individuals to join our team.
twitter.com/VergeGenomics
linkedin.com/company/verge-genomics
Founded in 2015, we’ve raised $32 million in Series A financing to build a next-generation biopharmaceutical company and are looking for exceptional individuals to join our team.
twitter.com/VergeGenomics
linkedin.com/company/verge-genomics
